The future of targeted therapies for brain metastases

Anna S Berghoff1,2, Matthias Preusser1,2

  • 1Department for Medicine I, Comprehensive Cancer Center Central Nervous System Unit (CCC-CNS), Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

Insights

Targeted therapies show promise for brain metastases (BM) in advanced cancer. This review explores existing and emerging treatments, focusing on challenges in clinical trials for BM patients.

Area of Science:

  • Oncology
  • Neurology
  • Pharmacology

Background:

  • Brain metastases (BM) pose a significant challenge in advanced cancer care.
  • Current treatment options for BM are limited, primarily relying on local therapies.
  • Systemic therapies, particularly targeted therapies, are under-investigated in BM due to trial exclusions.

Purpose of the Study:

  • To review existing and emerging targeted therapies for common primary tumor types of BM.
  • To discuss the challenges and considerations for conducting clinical trials on targeted therapies in BM patients.

Main Methods:

  • Literature review of targeted therapies for brain metastases.
  • Analysis of challenges in clinical trial design for BM patients.

Main Results:

  • Several targeted therapies demonstrate promising activity in patients with BM.
  • Key challenges include patient selection, combination with radiotherapy, overcoming the blood-brain barrier, and defining study endpoints.

Conclusions:

  • Targeted therapies represent a growing area of interest for managing brain metastases.
  • Addressing clinical trial challenges is crucial for advancing systemic treatment options for BM.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K